A new way to regulate protein levels and functions could be the answer to treating devastating neurological conditions
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).
At their root, these disorders are triggered by misbehaving proteins in the brain. The proteins misfold and accumulate in neurons, inflicting damage and eventually killing the cells. In a new study, researchers in the laboratory of Steven Finkbeiner, MD, PhD, at the Gladstone Institutes used a different protein, Nrf2, to restore levels of the disease-causing proteins to a normal, healthy range, thereby preventing cell death.
The researchers tested Nrf2 in two models of Parkinson’s disease: cells with mutations in the proteins LRRK2 and a-synuclein. By activating Nrf2, the researchers turned on several “house-cleaning” mechanisms in the cell to remove excess LRRK2 and a-synuclein.
“Nrf2 coordinates a whole program of gene expression, but we didn’t know how important it was for regulating protein levels until now,” explained first author Gaia Skibinski, PhD, a staff research scientist at Gladstone. “Overexpressing Nrf2 in cellular models of Parkinson’s disease resulted in a huge effect. In fact, it protects cells against the disease better than anything else we’ve found.”
In the study, published in the Proceedings of the National Academy of Sciences, the scientists used both rat neurons and human neurons created from induced pluripotent stem cells. They then programmed the neurons to express Nrf2 and either mutant LRRK2 or a-synuclein. Using a one-of-a-kind robotic microscope developed by the Finkbeiner laboratory, the researchers tagged and tracked individual neurons over time to monitor their protein levels and overall health. They took thousands of images of the cells over the course of a week, measuring the development and demise of each one.
The scientists discovered that Nrf2 worked in different ways to help remove either mutant LRRK2 or a-synuclein from the cells. For mutant LRRK2, Nrf2 drove the protein to gather into incidental clumps that can remain in the cell without damaging it. For a-synuclein, Nrf2 accelerated the breakdown and clearance of the protein, reducing its levels in the cell.
“I am very enthusiastic about this strategy for treating neurodegenerative diseases,” said Finkbeiner, a senior investigator at Gladstone and senior author on the paper. “We’ve tested Nrf2 in models of Huntington’s disease, Parkinson’s disease, and ALS, and it is the most protective thing we’ve ever found. Based on the magnitude and the breadth of the effect, we really want to understand Nrf2 and its role in protein regulation better.”
The scientists say that Nrf2 itself may be difficult to target with a drug because it is involved in so many cellular processes, so they are now focusing on some of its downstream effects. They hope to identify other players in the protein regulation pathway that interact with Nrf2 to improve cell health and that may be easier to drug.
Receive an email update when we add a new NEURODEGENERATIVE DISEASES article.
The Latest on: Regulate protein levels and functions
via Google News
The Latest on: Regulate protein levels and functions
- DeepMind accurately predicts protein structure, advancing decades-old challengeon November 30, 2020 at 6:34 pm
In a challenge where researchers try to predict the shape of newly identified proteins, an AI system developed by DeepMind determined the shape of two-thirds of proteins with an accuracy comparable to ...
- DeepMind AI breaks through decades-old protein folding puzzleon November 30, 2020 at 11:22 am
Researchers at DeepMind, Google’s artificial intelligence-focused sibling, believe they’ve now cracked the code, with a computer model that can translate a chain of amino acids into a 3D structure.
- Protein regulating inflammation in atherosclerosis identifiedon November 27, 2020 at 9:16 am
The protein CARD8 regulates several inflammatory proteins in people with atherosclerosis. This is shown in a new study by Örebro researchers published in the scientific journal Scientific Reports.
- CARD8 protein could be novel atherosclerosis drug targeton November 27, 2020 at 4:29 am
Researchers demonstrate that the CARD8 protein plays a key role in regulating the inflammation that causes atherosclerosis.
- CARD8 protein regulates inflammatory process in atherosclerosis, study showson November 26, 2020 at 3:22 pm
The protein CARD8 regulates several inflammatory proteins in people with atherosclerosis. This is shown in a new study by örebro researchers published in the scientific journal Scientific Reports.
- The Best Proteins for Women, According to Dietitianson November 20, 2020 at 12:35 pm
Protein is critical for improving bone density and promoting strength and wellness. Here are the best protein sources for women, according to dietitians.
- Investigators plant better AID for protein degradationon November 20, 2020 at 7:23 am
By transplanting a plant-specific degradation pathway controlled by a phytohormone, auxin, into non-plant cells, researchers at the Japanese National Institutes of Genetics have developed a rapid ...
- Drug discovery: First highly scalable method to monitor protein levels and localizationson November 17, 2020 at 10:47 am
Researchers at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, have developed a highly scalable method which allows for the study of hundreds of proteins in ...
- Study reveals the metabolic signaling mechanisms that regulate function of eTreg cellson November 16, 2020 at 3:59 pm
St. Jude Children's Research Hospital scientists have revealed the metabolic signaling mechanisms that regulate function of eTreg ... especially at the level of intracellular signaling, has ...
via Bing News